The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 21, 2023

Filed:

Oct. 31, 2018
Applicant:

The Research Foundation for the State University of New York, Albany, NY (US);

Inventors:

Jingfang Ju, East Setauket, NY (US);

Andrew Fesler, Sound Beach, NY (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 48/00 (2006.01); C07H 21/02 (2006.01); C12N 15/113 (2010.01); A61P 35/00 (2006.01); A61K 31/712 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
C12N 15/1135 (2013.01); A61K 31/712 (2013.01); A61K 45/06 (2013.01); A61K 48/00 (2013.01); A61P 35/00 (2018.01); C07H 21/02 (2013.01); C12N 2310/14 (2013.01); C12N 2310/141 (2013.01); C12N 2310/335 (2013.01); C12N 2310/3533 (2013.01);
Abstract

The present disclosure provides nucleic acid compositions that incorporate one or more halouracil molecules. More specifically, the present disclosure reveals that the replacement of uracil nucleotides within a microRNA nucleotide sequence with a 5-halouracil increases the ability of the micro-RNA to inhibit cancer progression and tumorigenesis. As such, the present disclosure provides various nucleic acid (e.g., microRNA) compositions having 5-halouracil molecules incorporated in their nucleic acid sequences and methods for using the same. The present disclosure further provides pharmaceutical compositions comprising the modified nucleic acid compositions, and methods for treating cancers using the same.


Find Patent Forward Citations

Ju, Jingfang. (2023). 5-halouracil-modified micrornas and their use in the treatment of cancer (U.S. Patent No. 11584932). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11584932

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…